Worth reading
44Recurring
Scored from 3 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
498
Units (unallocated stock acquisition rights)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Finalization of the issuance terms of the 10th Series Stock Acquisition Rights (stock options)
発行・処分する株式数
1,776,200 shares (17,762 stock acquisition rights × 100 shares per right)
Intended allottee
Name Directors of the company / Number of Employees 4 / Number of stock acquisition rights 3,300 rights, Name The Company's employees / Number of Employees 22 / Number of stock acquisition rights 8,000 rights, Name Directors of the company's subsidiaries / Number of Employees 2 / Number of stock acquisition rights 850, Name Employees of the company's subsidiaries / Number of Employees 97 / Number of stock acquisition rights 5,612
Terms of the stock acquisition rights
Exercise price
¥11,900 per stock acquisition right, or ¥119 per share. Adjustment provisions: Not disclosed
Number of Stock Acquisition Rights
Total to be issued: 17,762 rights; unallocated: 238 rights (260 of the 498 unallocated rights were reallocated to the Company's directors)
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 4 / Number allocated 3,300 rights, Category The Company's employees / Number of Employees 22 / Number allocated 8,000 rights, Category Directors of the company's subsidiaries / Number of Employees 2 / Number allocated 850, Category Employees of the company's subsidiaries / Number of Employees 97 / Number allocated 5,612
Procedures under the Corporate Code of Conduct
At the extraordinary general meeting of shareholders held on 18 July 2025, an allocation limit of 18,000 stock acquisition rights in total was approved. This issuance will be carried out within that limit.
| Item | Details |
|---|---|
| Type of issuance or disposal | Finalization of the issuance terms of the 10th Series Stock Acquisition Rights (stock options) |
| Number of shares to be issued or disposed of | 1,776,200 shares (17,762 stock acquisition rights × 100 shares per right) |
| Intended allottee | Name Directors of the company / Number of Employees 4 / Number of stock acquisition rights 3,300 rights, Name The Company's employees / Number of Employees 22 / Number of stock acquisition rights 8,000 rights, Name Directors of the company's subsidiaries / Number of Employees 2 / Number of stock acquisition rights 850, Name Employees of the company's subsidiaries / Number of Employees 97 / Number of stock acquisition rights 5,612 |
| Exercise price | ¥11,900 per stock acquisition right, or ¥119 per share. Adjustment provisions: Not disclosed |
| Number of Stock Acquisition Rights | Total to be issued: 17,762 rights; unallocated: 238 rights (260 of the 498 unallocated rights were reallocated to the Company's directors) |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 4 / Number allocated 3,300 rights, Category The Company's employees / Number of Employees 22 / Number allocated 8,000 rights, Category Directors of the company's subsidiaries / Number of Employees 2 / Number allocated 850, Category Employees of the company's subsidiaries / Number of Employees 97 / Number allocated 5,612 |
| Procedures under the Corporate Code of Conduct | At the extraordinary general meeting of shareholders held on 18 July 2025, an allocation limit of 18,000 stock acquisition rights in total was approved. This issuance will be carried out within that limit. |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Following the subscription process, changes to the eligible recipients occurred among some employees of the Company and its subsidiaries due to declined allocations and other circumstances. Of the unallocated rights, 260 were reallocated to the Company's directors to further strengthen the commitment of the directors responsible for the Company's corporate restructuring, and to promote rapid decision-making and execution aimed at enhancing the Group's medium- to long-term corporate value and improving its performance.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.